Literature DB >> 27605088

Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.

Nikita Joshi1,2, Jessica L Ray3, Anna K Kopec3,2, James P Luyendyk1,3,2.   

Abstract

Exposure of rodents to the xenobiotic α-naphthylisothiocyanate (ANIT) is an established model of experimental intrahepatic bile duct injury. Administration of ANIT to mice causes neutrophil-mediated hepatocellular necrosis. Prolonged exposure of mice to ANIT also produces bile duct hyperplasia and liver fibrosis. However, the mechanistic connection between ANIT-induced hepatocellular necrosis and bile duct hyperplasia and fibrosis is not well characterized. We examined impact of two different doses of ANIT, by feeding chow containing ANIT (0.05%, 0.1%), on the severity of various liver pathologies in a model of chronic ANIT exposure. ANIT-elicited increases in liver inflammation and hepatocellular necrosis increased with dose. Remarkably, there was no connection between increased hepatocellular necrosis and bile duct hyperplasia and peribiliary fibrosis, as these pathologies increased similarly in mice exposed to either dose of ANIT. The results indicate that the severity of hepatocellular necrosis does not dictate the extent of bile duct hyperplasia/fibrosis in ANIT-exposed mice.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ANIT; alpha-naphthylisothiocyanate; bile duct; biliary hyperplasia; fibrosis; hepatocellular necrosis; liver

Mesh:

Substances:

Year:  2016        PMID: 27605088      PMCID: PMC5509966          DOI: 10.1002/jbt.21834

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  36 in total

1.  The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis.

Authors:  Bradley P Sullivan; Paul H Weinreb; Shelia M Violette; James P Luyendyk
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

2.  Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.

Authors:  James P Luyendyk; Karen M Kassel; Katryn Allen; Grace L Guo; Guodong Li; Glenn H Cantor; Bryan L Copple
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

3.  The nature of alpha-naphthylisothiocyanate-induced cholestasis.

Authors:  B A Becker; G L Plaa
Journal:  Toxicol Appl Pharmacol       Date:  1965-09       Impact factor: 4.219

Review 4.  The pathology of cholestasis.

Authors:  Melissa K Li; James M Crawford
Journal:  Semin Liver Dis       Date:  2004-02       Impact factor: 6.115

5.  An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury.

Authors:  L J Dahm; A E Schultze; R A Roth
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

6.  Role of alphavbeta6 integrin in acute biliary fibrosis.

Authors:  Bruce Wang; Brian M Dolinski; Noriko Kikuchi; Diane R Leone; Marion G Peters; Paul H Weinreb; Shelia M Violette; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

Review 7.  Role of hemostatic factors in hepatic injury and disease: animal models de-liver.

Authors:  A K Kopec; N Joshi; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2016-05-10       Impact factor: 5.824

8.  Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.

Authors:  Jeon-Ok Moon; Timothy P Welch; Frank J Gonzalez; Bryan L Copple
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

Review 9.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

10.  Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.

Authors:  Tsutomu Fujii; Bryan C Fuchs; Suguru Yamada; Gregory Y Lauwers; Yakup Kulu; Jonathan M Goodwin; Michael Lanuti; Kenneth K Tanabe
Journal:  BMC Gastroenterol       Date:  2010-07-09       Impact factor: 3.067

View more
  9 in total

1.  Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.

Authors:  Nikita Joshi; Anna K Kopec; Holly Cline-Fedewa; James P Luyendyk
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

2.  Effects of human amnion-derived mesenchymal stem cells and conditioned medium in rats with sclerosing cholangitis.

Authors:  Ryo Sugiura; Shunsuke Ohnishi; Masatsugu Ohara; Marin Ishikawa; Shuichi Miyamoto; Reizo Onishi; Koji Yamamoto; Kazumichi Kawakubo; Masaki Kuwatani; Naoya Sakamoto
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

3.  Von Willebrand factor exerts hepatoprotective effects in acute but not chronic cholestatic liver injury in mice.

Authors:  Lauren G Poole; Anna-Katherine Fournier; Holly M Cline-Fedewa; Anna K Kopec; James P Luyendyk; Dafna J Groeneveld
Journal:  Toxicology       Date:  2021-10-04       Impact factor: 4.571

4.  Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis.

Authors:  Nazi Song; Hongjiao Xu; Jiahua Liu; Qian Zhao; Hui Chen; Zhibin Yan; Runling Yang; Zhiteng Luo; Qi Liu; Jianmei Ouyang; Shuohan Wu; Suijia Luo; Shuyin Ye; Runfeng Lin; Xi Sun; Junqiu Xie; Tian Lan; Zhongdao Wu; Rui Wang; Xianxing Jiang
Journal:  Acta Pharm Sin B       Date:  2021-12-29       Impact factor: 14.903

5.  A Network Pharmacology Study of the Molecular Mechanisms of Hypericum japonicum in the Treatment of Cholestatic Hepatitis with Validation in an Alpha-Naphthylisothiocyanate (ANIT) Hepatotoxicity Rat Model.

Authors:  Sen Ling Feng; Jing Zhang; Hongliu Jin; Wen Ting Zhu; Zhongwen Yuan
Journal:  Med Sci Monit       Date:  2021-03-03

Review 6.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

Review 7.  Cholestasis-Associated Pruritus and Its Pruritogens.

Authors:  Jacqueline A G M Langedijk; Ulrich H Beuers; Ronald P J Oude Elferink
Journal:  Front Med (Lausanne)       Date:  2021-03-09

8.  Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis.

Authors:  YueHua Zhou; YunZhong Zhou; YiFei Li; Wei Sun; ZhaoLong Wang; Long Chen; Ye He; XiaoLong Niu; Jialiang Chen; Guangtao Yao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

9.  Liver fibrosis is driven by protease-activated receptor-1 expressed by hepatic stellate cells in experimental chronic liver injury.

Authors:  Lauren G Poole; Asmita Pant; Holly M Cline-Fedewa; Kurt J Williams; Bryan L Copple; Joseph S Palumbo; James P Luyendyk
Journal:  Res Pract Thromb Haemost       Date:  2020-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.